Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- INMUNOGLOBULINA HUMANA NORMAL — 200 mg
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- All 4 packs marketed
Packs
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 5 ml
1 pcs
National code
Marketed732751Strength of this pack 200 mg
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 10 ml
1 pcs
National code
Marketed732752Strength of this pack 200 mg
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 20 ml
1 pcs
National code
Marketed732753Strength of this pack 4 g
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 50 ml
1 pcs
National code
Marketed732754Strength of this pack 200 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 86544Official data
- Marketing authorisation holder
- INSTITUTO GRIFOLS S.A.Official data
- Authorised
- Mar 3, 2022Official data
- Authority form code
- 197Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.